Nikolas Haass

Professor Nikolas Haass is a clinician-scientist at the Frazer Institute (University of Queensland) with expertise in melanoma cell biology and experimental therapy. His research focuses on dynamic tumor heterogeneity, combining real-time cell cycle imaging in 3D cultures and in vivo models with biochemical methods to study melanomagenesis and therapeutic targeting.

• University of Heidelberg (MD, Cell Biology PhD)
• University of Hamburg (Clinical Dermatology)
• Wistar Institute (Postdoc, 2003-2007)
• Centenary Institute/University of Sydney (Associate Faculty, 2007-2013)
• UQ Diamantina Institute (2013-2016 as Associate Professor, then promoted to Professor)

His team has published 97 high-impact papers with >7500 citations, including landmark studies in Molecular Cancer Therapeutics, Cancer Research, and PNAS that were highlighted by Faculty 1000 Biology. Current grants include projects on tumor microenvironment modulation, endoplasmic reticulum stress induction, and melanoma brain metastasis therapy. He supervises multiple PhD students in areas including MITF-CDK4/6 interactions and 3D spheroid proteomics. His work bridges tumor-stroma interactions, immunogenic cell death, and advanced imaging technologies.